Literature DB >> 33793305

Imaging after percutaneous thermal and non-thermal ablation of hepatic tumour: normal appearances, progression and complications.

Germain Bréhier1, Louis Besnier1, Anaïs Delagnes1, Frédéric Oberti2,3, Jérôme Lebigot1, Christophe Aubé1,3, Anita Paisant1,3.   

Abstract

The increasing number of liver tumours treated by percutaneous ablation leads all radiologists to be confronted with the difficult interpretation of post-ablation imaging. Radiofrequency and microwave techniques are most commonly used. Recently, irreversible electroporation treatments that do not induce coagulation necrosis but cellular apoptose and respect the collagen architecture of bile ducts and vessels have been introduced and lead to specific post-ablation features and evolution. Ablations cause 'normal' changes in ablation and periablation zones. It is necessary to know these post-ablation features to avoid the misinterpretation of recurrence or complication that would lead to unnecessary treatments. Another challenge for the radiologist is to detect as early as possible the residual unablated tumour or the disease progression (local progression and tumour seeding) that will require a new treatment. Finally, the complications, frequent or rarer, should be recognised to be managed adequately. The purpose of this article is therefore to describe the large spectrum of normal and pathological aspects related to the treatment of hepatic tumour by percutaneous thermal ablation and irreversible electroporation ablation.

Entities:  

Mesh:

Year:  2021        PMID: 33793305      PMCID: PMC8248226          DOI: 10.1259/bjr.20201327

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  15 in total

1.  The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.

Authors:  Young-Sun Kim; Won Jae Lee; Hyunchul Rhim; Hyo K Lim; Dongil Choi; Ji Young Lee
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

2.  Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results.

Authors:  Christina Schraml; Nina F Schwenzer; Stephan Clasen; Hans-Joerg Rempp; Petros Martirosian; Claus D Claussen; Philippe L Pereira
Journal:  J Magn Reson Imaging       Date:  2009-06       Impact factor: 4.813

Review 3.  Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 2, Abnormal findings.

Authors:  Nisha I Sainani; Debra A Gervais; Peter R Mueller; Ronald S Arellano
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

4.  Assessment of liver tumor response by high-field (3 T) MRI after radiofrequency ablation: short- and mid-term evolution of diffusion parameters within the ablation zone.

Authors:  Tri-Linh Lu; Fabio Becce; Pierre Bize; Alban Denys; Reto Meuli; Sabine Schmidt
Journal:  Eur J Radiol       Date:  2012-07-19       Impact factor: 3.528

5.  Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.

Authors:  H K Lim; D Choi; W J Lee; S H Kim; S J Lee; H J Jang; J H Lee; J H Lim; I W Choo
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

6.  Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.

Authors:  Y Kondo; H Yoshida; S Shiina; R Tateishi; T Teratani; M Omata
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

7.  Needle track seeding after percutaneous microwave ablation of malignant liver tumors under ultrasound guidance: analysis of 14-year experience with 1462 patients at a single center.

Authors:  Jie Yu; Ping Liang; Xiao-ling Yu; Zhi-gang Cheng; Zhi-yu Han; Bao-wei Dong
Journal:  Eur J Radiol       Date:  2011-12-01       Impact factor: 3.528

8.  Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.

Authors:  Marco Dollinger; Florian Zeman; Christoph Niessen; Sven A Lang; Lukas P Beyer; Martina Müller; Christian Stroszczynski; Philipp Wiggermann
Journal:  J Vasc Interv Radiol       Date:  2016-01       Impact factor: 3.464

9.  Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.

Authors:  Marco Dollinger; René Müller-Wille; Florian Zeman; Michael Haimerl; Christoph Niessen; Lukas P Beyer; Sven A Lang; Andreas Teufel; Christian Stroszczynski; Philipp Wiggermann
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

10.  Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.

Authors:  Jonas Scheck; Philipp Bruners; David Schindler; Christiane Kuhl; Peter Isfort
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.